Patents by Inventor Jianjia ZHENG

Jianjia ZHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl compounds as kinase inhibitor
    Patent number: 11767296
    Abstract: Provided herein are compounds of formula (I) having activity on a receptor protein tyrosine kinase, wherein R1, R2, R3, A, Q, Z, X and W are set forth in the description, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: September 26, 2023
    Assignee: FUJIAN HAIXI PHARMACEUTICALS CO., LTD
    Inventors: Yan Feng, Ruyong Wang, Junqing Li, Jianjia Zheng, Xin Lian, Xuan Gong, Yueli Fu, Xinshan Kang
  • HETEROARYL COMPOUNDS AS KINASE INHIBITOR
    Publication number: 20220380312
    Abstract: Provided herein are compounds of formula (I) having activity on a receptor protein tyrosine kinase, wherein R1, R2, R3, A, Q, Z, X and W are set forth in the description, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 13, 2019
    Publication date: December 1, 2022
    Applicant: FUJIAN HAIXI PHARMACEUTICALS CO., LTD
    Inventors: Yan FENG, Ruyong WANG, Junqing LI, Jianjia ZHENG, Xin LIAN, Xuan GONG, Yueli FU, Xinshan KANG